menu
    • menu

    Company profile for Atavistik Bio

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Atavistik Bio’s high-throughput platform for the unbiased identification of metabolite-protein interactions, will enable us to discover first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control. Our unique approach marries this validated platform with structure-aided drug design capabilities and cutting-edge insights into the regulation of metabolic systems—including clinical metabolomi...
    Atavistik Bio’s high-throughput platform for the unbiased identification of metabolite-protein interactions, will enable us to discover first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control. Our unique approach marries this validated platform with structure-aided drug design capabilities and cutting-edge insights into the regulation of metabolic systems—including clinical metabolomic data sets—to apply to genetically-validated targets in metabolic diseases and cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Atavistik BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.atavistikbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atavistik Bio Secures $40M Series B Extension, Totaling $160M
    Atavistik Bio Secures $40M Series B Extension, Totaling $160M

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3249997/0/en/Atavistik-Bio-Closes-40-Million-Series-B-Extension-for-Advancement-of-its-Pipeline-Bringing-Total-Round-Proceeds-to-160-Million.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Atavistik Bio Secures $120M For Allosteric Therapeutics In (HHT)
    Atavistik Bio Secures $120M For Allosteric Therapeutics In (HHT)

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207561/0/en/Atavistik-Bio-Raises-120-Million-Series-B-Financing-to-Advance-the-Development-of-Selective-Allosteric-Small-Molecule-Therapeutics-for-the-Treatment-of-Hereditary-Hemorrhagic-Telan.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Atavistik Bio To Unveil JAK2 V617F Mutant-Selective Inhibitors
    Atavistik Bio To Unveil JAK2 V617F Mutant-Selective Inhibitors

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199642/0/en/Atavistik-Bio-to-Present-Discovery-of-JAK2-V617F-Mutant-Selective-Allosteric-Inhibitors-for-the-Treatment-of-Myeloproliferative-Neoplasms-MPNs-at-ASH-2025.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Atavistik Bio Appoints Susan Pandya as Chief Medical Officer
    Atavistik Bio Appoints Susan Pandya as Chief Medical Officer

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3149860/0/en/Atavistik-Bio-Expands-Leadership-Team-with-Appointment-of-Susan-Pandya-M-D-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    Atavistik Bio Doses First Patient in Phase 1 Trial of ATV-1601
    Atavistik Bio Doses First Patient in Phase 1 Trial of ATV-1601

    04 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/04/3126441/0/en/Atavistik-Bio-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ATV-1601-in-Patients-with-AKT1-E17K-mutant-Solid-Tumors.html

    GLOBENEWSWIRE
    04 Aug 2025
    Share Share
    Atavistik Bio Appoints William Sellers, M.D. to Advisory Board
    Atavistik Bio Appoints William Sellers, M.D. to Advisory Board

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052131/0/en/Atavistik-Bio-Announces-Appointment-of-William-Sellers-M-D-to-its-Scientific-Advisory-Board.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search